4-(Aminomethyl)-5-(hydroxymethyl)-2-methylpyridin-3-ol dihydrochloride, 95.0%, 1g

GC capillary column ROTI®Cap-1, 60 m, 0.25 mm, 1.00 µm, 1 Piece(s)

Ethyl 5-chloro-3-methylisoxazole-4-carboxylate, 95.0%, 1g

1-(Naphthalen-1-yl)cyclopropane-1-carbonitrile, 98%, 5g

5-Nitro-1H-pyrrolo[2,3-b]pyridine-3-carbaldehyde, 97%, 1g

2-Bromo-3'-chloro-4'-fluorobenzophenone, 97.0%, 1g

ethyl (2Z)-2-chloro-2-[2-(2-chloro-4-nitrophenyl)hydrazin-1-ylidene]acetate, 95.0%, 10g

(R)-Octan-2-yl 4-((4-(hexyloxy)benzoyl)oxy)benzoate, 97.0%, 10g

(S)-1-(tert-Butoxycarbonyl)-3-methylpyrrolidine-3-carboxylic acid, 98%, 500mg

Trifluoropyruvic acid monohydrate, 97.0%, 1g

4-Bromo-2,6-diisopropylaniline, 95.0%, 100g

5-Phenyl-3H-thieno[2,3-d]pyrimidin-4-one, 95.0%, 1g

2-(pyridin-2-yl)-3,4-dihydropyrimidin-4-one, 95%, 100mg